IFNL3 and glycogen storage disease VI: Plasma levels of IP-10 have proven to be a valid correlate for HCV fibrosis [18], a measure of chronic HCV disease activity [19], and an IL-28b independent negative predictor of treatment effect[4]–[7], [11], [19].